[4-(Heteroaryl) piperazin1-yl]-(2,5-substituted - phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders

Details for Australian Patent Application No. 2005324024 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Jolidon, Synese; Pinard, Emmanuel; Norcross, Roger David; Narquizian, Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2005324024

PCT Pub. Number WO2006/072436

Priority 05100077.6 07.01.05 EP

Filing date 28 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 17 February 2011

International Classifications

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/08 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 285/12 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/072436 Priority application(s): WO2006/072436

17 February 2011 Application Accepted

  Published as AU-B-2005324024

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005324026-Milk powder

2005324023-Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders